Pharmaceutical Medicine Programs
Please note: The Pharmaceutical Medicine program will be undergoing changes in 2017. We will be updating the materials on this page shortly.
Direct enrolments will no longer be accepted for 9060, 5504 or 7370.
For up-to-date information, please contact the Pharm Med team, and refer to the Handbook entry for the new program (9370, Pharmaceutical Medicine).
For Australia to play its full role in the development of new drugs, particularly in the early phase of drug development, and to maintain high standards of delivery of drugs to the market, it is essential that Australian pharmaceutical companies have staff adequately trained and skilled to perform in these areas. Training in these skills must meet assessable standards which are compatible with international scientific, clinical, legal and regulatory conventions. This is important for Australia to compete in local and international drug development activities and for the career development of those involved.
Those working in Research & Development, Medical, Medical Information and Regulatory Departments in pharmaceutical companies are responsible for the discovery and selection of new drugs for development, their evaluation for efficacy and safety in preclinical and clinical studies, pharmacovigilance (e.g. monitoring and reporting of adverse drug reactions), registration of new drugs and associated regulatory activities, pharmacoeconomic studies, and other activities.
The UNSW programs in Pharmaceutical Medicine have been designed to ensure staff are adequately equipped with the skills needed to competently perform their roles in the industry.
The programs also provide an excellent opportunity for recent graduates in Medical Sciences, and those in a variety of research positions to upgrade skills.
The Prospectus provides detailed information on the Programs in the Development of New Medicines offered.